– Company opens San Francisco area office –
VANCOUVER, March 18, 2016 /CNW/ – ProNAi Therapeutics, Inc. (NASDAQ: DNAI), a clinical-stage oncology company advancing novel therapeutics for patients with cancer and hematological diseases, today announced the appointments of Mr. Jeffrey H….